ClinicalTrials.Veeva

Menu

Validation of the Zigzag Tracking Task Test for the Evaluation of Handwriting Difficulties in Writer's Cramp (LabyDys)

F

Fondation Ophtalmologique Adolphe de Rothschild

Status

Terminated

Conditions

Dystonic Disorder

Treatments

Other: Validation of a handwriting scale

Study type

Observational

Funder types

NETWORK

Identifiers

NCT02882295
SSA_2016_10

Details and patient eligibility

About

Writer's cramp (WC) is a task specific dystonia that occurs from the moment patient starts writing. It leads to partial or complete inability to use the hand only during the handwriting gesture. It is characterized by the appearance of cramps or spasms of certain muscles of the hand and/or forearm.

Clinical scales currently use for the assessment of WC fail to accurately reflect changes in the characteristics of handwriting in response to treatments (Botulinum Neurotoxin injections and / or retraining therapy).

The Zigzag Tracking Task (ZZTT), easy to use in current practice provides useful information in terms of speed and precision of handwriting gesture. This timed handwriting test is to follow with a pen a zigzag path beset with obstacles to avoid. It permits to evaluate the time in seconds required to carry out the zigzag path and count the number of errors (output path and contacts with obstacles). The investigators propose to validate the ZZTT for the assessment of the handwriting gesture of WC.

Enrollment

23 patients

Sex

All

Ages

18 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • scholarship in French language, at least until 16 years old
  • writer's cramp (diagnostic confirmed by a neurologist specialized in movement disorders)
  • prescription of botulinum neurotoxin injection
  • prescription de novo or absence of injection in the last 3 months
  • informed consent
  • medical insurance coverage

Exclusion criteria

  • writing tremor
  • -other neurological disease with effect on handwriting
  • pain or traumatism of the upper limb, with effect on handwriting
  • non-corrected visual disturbances
  • patient living outside the region where the study will be held (Ile-de-France)
  • participation in another research with a potential impact on evaluation criteria
  • pregnant or breast feeding patient
  • patient under judiciary protection

Trial design

23 participants in 2 patient groups

writer's cramp
Description:
patients assessed without, then with Botulinum Neurotoxin injections
Treatment:
Other: Validation of a handwriting scale
control
Description:
age and gender matched
Treatment:
Other: Validation of a handwriting scale

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems